Formulation evidence map · Published July 22, 2026 · Sources checked July 22, 2026

SculptAxis research kit overview

SculptAxis contains four separately identified catalog materials. No cited primary source documents the exact kit as a single material.

Evidence boundary: ingredient studies do not establish the behavior of this exact formulation. The catalog product is offered only for lawful nonclinical laboratory research and is not for human or veterinary use.

What is SculptAxis kit?

Modified GRF(1-29), Ipamorelin, Tesamorelin, and Tirzepatide are distinct substances. Each component requires its own identity record and lot-linked analytical documentation.

Research category
Formulations & research kits
Study models represented
Ingredient identity and analytical documentation
Names in the literature
SculptAxis blend
Primary boundary
No cited source verifies the commercial kit as a combined material.

What does the selected evidence support?

A kit label does not establish component identity, compatibility, purity, or combined behavior. Those questions require material-specific methods and controls.

Primary sources

  1. Ranke et al. (1986) — GRF(1-29)-amide research; not a kit study. DOI: 10.1007/BF02429048
  2. Raun et al. (1998) — Ipamorelin research; not a kit study. DOI: 10.1530/eje.0.1390552
  3. Coskun et al. (2018) — Tirzepatide research; not a kit study. DOI: 10.1016/j.molmet.2018.09.009

Ingredient evidence reviews

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.